Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Participants
2.2. Measures
Sociodemographic and Vaccine-Related Information
2.3. Statistical Analysis
3. Results
4. Discussion
5. Strengths and Limitations
6. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- WHO Coronavirus (COVID-19) Dashboard. Who.int. 2021. Available online: https://covid19.who.int/ (accessed on 15 April 2022).
- Zeegers Paget, D.; Allebeck, P.; Nagyova, I. COVID-19: What have we learned? What are the public health challenges? Eur. J. Public Health 2021, 31, iv1–iv2. [Google Scholar] [CrossRef]
- Tenforde, M.W.; Self, W.H.; Adams, K.; Gaglani, M.; Ginde, A.A.; McNeal, T. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA 2021, 326, 2043–2054. [Google Scholar] [CrossRef]
- Lauring, A.S.; Tenforde, M.W.; Chappell, J.D.; Gaglani, M.; Ginde, A.A.; McNeal, T.; Ghamande, S.; Douin, D.J.; Talbot, H.K.; Casey, J.D.; et al. Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study. Br. Med. J. 2022, 376, e069761. [Google Scholar] [CrossRef]
- Mathieu, E.; Ritchie, H.; Ortiz-Ospina, E.; Roser, M.; Hasell, J.; Appel, C.; Giattino, C.; Rodés-Guirao, L. A global database of COVID-19 vaccinations. Nat. Hum. Behav. 2021, 5, 947–953. [Google Scholar] [CrossRef]
- Wrenn, J.O.; Pakala, S.B.; Vestal, G.; Shilts, M.H.; Brown, H.M.; Bowen, S.M.; Strickland, B.A.; Williams, T.; Mallal, S.A.; Jones, I.D.; et al. COVID-19 severity from Omicron and Delta SARS-CoV-2 variants. Influenza Other Respir. Viruses 2022, in press. [Google Scholar] [CrossRef]
- Gordon, A.L.; Achterberg, W.P.; van Delden, J.J. Mandatory vaccination against COVID-19 for health and social care workers caring for older people. Age Ageing 2022, 51, afac097. [Google Scholar] [CrossRef]
- Maltezou, H.C.; Tseroni, M.; Drositis, I.; Gamaletsou, M.N.; Koukou, D.M.; Bolikas, E.; Peskelidou, E.; Daflos, C.; Panagiotaki, E.; Ledda, C.; et al. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece. Exp. Rev. Vaccines 2022, in press. [Google Scholar] [CrossRef]
- Rieger, T.; Schmidt-Petri, C.; Schröder, C. Attitudes Toward Mandatory COVID-19 Vaccination in Germany—A Representative Analysis of Data from the Socio-Economic Panel for the Year 2021. Dtsch. Arztebl. Int. 2022, in press. [Google Scholar] [CrossRef]
- Woolf, K.; Gogoi, M.; Martin, C.A.; Papineni, P.; Lagrata, S.; Nellums, L.B.; McManus, I.C.; Guyatt, A.L.; Melbourne, C.; Bryant, L.; et al. Healthcare workers’ views on mandatory SARS-CoV-2 vaccination in the UK: A cross-sectional, mixed-methods analysis from the UK-REACH study. EClinicalMedicine 2022, 46, 101346. [Google Scholar] [CrossRef]
- Largent, E.A.; Persad, G.; Sangenito, S.; Glickman, A.; Boyle, C.; Emanuel, E.J. US Public Attitudes toward COVID-19 Vaccine Mandates. JAMA Netw. Open 2020, 3, e2033324. [Google Scholar] [CrossRef]
- Statement on Omicron Sublineage BA.2. Who.int. Available online: https://www.who.int/news/item/22-02-2022-statement-on-omicron-sublineage-ba.2 (accessed on 10 April 2022).
- Pavia, C.S. Pasteur, Vaccines, and the Refusal to Become Fully Vaccinated in the Midst of the COVID-19 Pandemic. Front. Public Health 2022, 10, 815816. [Google Scholar] [CrossRef] [PubMed]
- UNESCO Statistics. International Standard Classification of Education (ISCED); UNESCO: Montreal, QC, Canada, 1997. [Google Scholar]
- Graeber, D.; Schmidt-Petri, C.; Schröder, C. Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany. PLoS ONE 2021, 16, e0248372. [Google Scholar] [CrossRef] [PubMed]
- Gagneux-Brunon, A.; Botelho-Nevers, E.; Bonneton, M.; Peretti-Watel, P.; Verger, P.; Launay, O.; Ward, J.K. Public opinion on a mandatory COVID-19 vaccination policy in France: A cross-sectional survey. Clin. Microbiol. Infect. 2022, 28, 433–439. [Google Scholar] [CrossRef] [PubMed]
- Giannakou, K.; Kyprianidou, M.; Heraclides, A. Attitudes and determinants of mandatory vaccination against COVID-19 among the general population of Cyprus: A nationwide cross-sectional study. Vaccines 2022, 10, 438. [Google Scholar] [CrossRef] [PubMed]
- Dong, E.; Du, H.; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020, 20, 533–534. [Google Scholar] [CrossRef]
- Ritchie, H.; Mathieu, E.; Rodés-Guirao, L.; Appel, C.; Giattino, C.; Ortiz-Ospina, E.; Hasell, J.; Macdonald, B.; Beltekian, D.; Roser, M. Coronavirus Pandemic (COVID-19). Our World in Data. 2020. Available online: https://ourworldindata.org/covid-vaccinations?country=ESP (accessed on 30 April 2022).
- Mohammed, I.; Nauman, A.; Paul, P.; Ganesan, S.; Chen, K.-H.; Jalil, S.M.S.; Jaouni, S.H.; Kawas, H.; Khan, W.A.; Vattoth, A.L.; et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum. Vaccines Immunother. 2022, 18, 2027160. [Google Scholar] [CrossRef] [PubMed]
- Wilder-Smith, A. What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant? Lancet Infect. Dis. 2021, 22, 152–153. [Google Scholar] [CrossRef]
- CoVariants: Per Country. Covariants.org. Available online: https://covariants.org/per-country (accessed on 1 May 2022).
- Rashedi, R.; Samieefar, N.; Masoumi, N.; Mohseni, S.; Rezaei, N. COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts. J. Med. Virol. 2021, 94, 1294–1299. [Google Scholar] [CrossRef]
- Tada, T.; Zhou, H.; Dcosta, B.M.; Samanovic, M.I.; Chivukula, V.; Herati, R.S.; Hubbard, S.R.; Mulligan, M.J.; Landau, N.R. Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies. ebioMedicine 2022, 78, 103944. [Google Scholar] [CrossRef]
- Andrews, N.; Stowe, J.; Kirsebom, F.; Toffa, S.; Rickeard, T.; Gallagher, E.; Gower, C.; Kall, M.; Groves, N.; O’Connell, A.-M.; et al. COVID-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N. Engl. J. Med. 2022, 386, 1532–1546. [Google Scholar] [CrossRef]
- Lopez Bernal, J.; Gower, C.; Andrews, N. Public Health England Delta Variant Vaccine Effectiveness Study Effectiveness of COVID-19 Vaccines against the B. 1.617. 2 (Delta) Variant. Reply. N. Engl. J. Med. 2021, 385, e92. [Google Scholar] [PubMed]
- Galasso, V.; Pons, V.; Profeta, P.; Becher, M.; Brouard, S.; Foucault, M. Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries. Proc. Natl. Acad. Sci. USA 2020, 117, 27285–27291. [Google Scholar] [CrossRef] [PubMed]
- Gallè, F.; Sabella, E.A.; Roma, P.; Da Molin, G.; Diella, G.; Montagna, M.T.; Ferracuti, S.; Liguori, G.; Orsi, G.B.; Napoli, C. Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy. Vaccines 2021, 9, 1222. [Google Scholar] [CrossRef] [PubMed]
- Iguacel, I.; Maldonado, A.L.; Ruiz-Cabello, A.L.; Casaus, M.; Moreno, L.A.; Martínez-Jarreta, B. Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain. Vaccines 2021, 9, 1321. [Google Scholar] [CrossRef] [PubMed]
- Wu, Q.; Dudley, M.Z.; Chen, X.; Bai, X.; Dong, K.; Zhuang, T.; Salmon, D.; Yu, H. Evaluation of the safety profile of COVID-19 vaccines: A rapid review. BMC Med. 2021, 19, 173. [Google Scholar] [CrossRef]
- Maltezou, H.C.; Anastassopoulou, C.; Hatziantoniou, S.; Poland, G.A.; Tsakris, A. Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines. Vaccine 2022, 40, 183–186. [Google Scholar] [CrossRef]
- Davies, D.; McDougall, A.; Yoong, W. COVID-19 vaccination during pregnancy: Coverage and safety, a comment. Am. J. Obstet. Gynecol. 2022, in press. [Google Scholar] [CrossRef]
- Male, V. SARS-CoV-2 infection and COVID-19 vaccination in pregnancy. Nat. Rev. Immunol. 2022, 22, 277–282. [Google Scholar] [CrossRef]
- Iguacel, I.; Luna Maldonado, A.; Luna Ruiz-Cabello, A.; Samatán, E.; Alarcón, J.; Orte, M.Á.; Mateos, S.S.; Martínez-Jarreta, B. Attitudes of healthcare professionals and general population toward vaccines and the intention to be vaccinated against COVID-19 in Spain. Front. Public Health 2021, 9, 739003. [Google Scholar] [CrossRef]
- Zürcher, K.; Mugglin, C.; Egger, M.; Müller, S.; Fluri, M.; Bolick, L.; Piso, R.J.; Hoffmann, M.; Fenner, L. Vaccination willingness for COVID-19 among healthcare workers: A cross-sectional survey in a Swiss canton. Swiss Med. Wkly. 2021, 151, w30061. [Google Scholar]
- Education at a Glance. OECD. Oecd-ilibrary.org. Available online: https://www.oecd-ilibrary.org/education/education-at-a-glance-2021_e7fdaf2e-en (accessed on 3 May 2022).
N = 3026 | N (%) | No (%) | Yes, for Everyone (%) | Yes, but Only for Some Sectors (%) | p-Value |
---|---|---|---|---|---|
Age (in years) * | |||||
18–25 | 1215 (40.2) | 21.2 | 70.8 | 8 | <0.000 |
26–35 | 539 (17.8) | 26.2 | 68.8 | 5 | |
36–50 | 780 (25.8) | 23.2 | 70.5 | 6.3 | |
51–64 | 375 (12.4) | 16 | 74.7 | 9.3 | |
>65 | 117 (3.9) | 14.5 | 77.8 | 7.7 | |
Gender * | |||||
Male | 1008 (33.3) | 23.9 | 66.6 | 9.5 | <0.000 |
Female | 2018 (66.7) | 20.6 | 73.4 | 6 | |
Healthcare setting | |||||
No | 1902 (62.9) | 22.5 | 69.9 | 7.6 | 0.132 |
Yes | 1124 (37.1) | 20.4 | 73.2 | 6.4 | |
Education * | |||||
Low | 703 (23.2) | 19.3 | 72.5 | 8.1 | 0.03 |
Medium | 782 (25.8) | 19.7 | 74.2 | 6.1 | |
High | 1541 (50.9) | 23.8 | 68.9 | 7.3 | |
Country * | |||||
Colombia | 1219 (40.3) | 18.2 | 77.4 | 4.2 | <0.000 |
El Salvador | 425 (14.0) | 21.4 | 71.5 | 7.1 | |
Spain | 1382 (45.7) | 24.9 | 65.4 | 9.7 | |
Forefront COVID-19 * | |||||
No | 2024 (66.9) | 23.7 | 68.3 | 8 | <0.000 |
Sometimes | 381 (12.6) | 18.1 | 74.8 | 7.1 | |
Yes | 621 (20.5) | 17.4 | 77.9 | 4.7 | |
Occupation * | |||||
Students/Unemployed/Retired. | 1042 | 20.2 | 70.7 | 9 | 0.001 |
Administrative staff | 20 (0.7) | 10 | 85 | 5 | |
Auxiliary or technician | 138 (4.6) | 18.8 | 76.8 | 4.3 | |
Commercial | 33 (1.1) | 12.1 | 84.8 | 3 | |
Nurse | 264 (8.7) | 21.2 | 74.6 | 4.2 | |
Medical Doctor (MD) | 222 (7.3) | 18.9 | 72.1 | 9 | |
Other health professionals different from MDs or nurses | 121 (4.0) | 15.7 | 81.8 | 2.5 | |
Non-sanitary | 1186 (39.2) | 25 | 68.1 | 6.8 | |
Vaccination status * | |||||
No, because I was not prioritized yet | 136 (4.5) | 19.1 | 75.7 | 5.1 | <0.000 |
No, because I had the COVID-19 | 78 (2.6) | 20.5 | 74.4 | 5.1 | |
No, because I refused to | 142 (4.7) | 84.5 | 10.6 | 4.9 | |
Only partially (one-dose) | 203 (6.7) | 18.9 | 72.1 | 9 | |
Only partially because I had the COVID-19 | 96 (3.2) | 25 | 63.5 | 25 | |
Yes, and I got the necessary doses | 2371 (78.4) | 18.1 | 74.4 | 7.4 | |
Violation of human rights in mandatory vaccines * | |||||
No | 1909 (63.1) | 7.6 | 87.8 | 4.5 | <0.000 |
I do not know | 266 (8.8) | 25.9 | 58.3 | 15.8 | |
Yes | 851 (28.1) | 51.9 | 37.6 | 10.5 | |
Third or subsequent doses * | |||||
No | 300 (9.9) | 66 | 27 | 7 | <0.000 |
I would have doubts | 283 (9.4) | 39.9 | 46.6 | 13.4 | |
Yes | 2443 (80.7) | 14.2 | 79.4 | 6.5 |
N = 3026 | N | % |
---|---|---|
PCR test or antigens to accede to leisure activities (i.e., restaurants, cinema, theatre, gym, to travel) | ||
No | 870 | 28.8 |
I don’t know | 251 | 8.3 |
Yes | 1905 | 63.0 |
PCR test or antigens to accede to official buildings or workplaces | ||
No | 903 | 29.8 |
I don’t know | 289 | 9.6 |
Yes | 1834 | 60.6 |
Suspension from work without pay | ||
No | 2029 | 67.1 |
I don’t know | 508 | 16.8 |
Yes | 489 | 16.2 |
Yes, for Everyone vs. No | Only for Some Sectors vs. No | |||
---|---|---|---|---|
Gender | aOR | 95% CI | aOR | 95% CI |
Male | 0.77 | 0.63–0.94 | 1.36 | 0.97–1.89 |
Female | 1.00 | Reference | 1.00 | Reference |
Age | 1.01 | 1.00–1.01 | 1.00 | 0.99–1.02 |
Country | ||||
Colombia | 1.68 | 1.36–2.08 | 0.32 | 0.20–0.51 |
El Salvador | 1.33 | 0.99–1.78 | 0.62 | 0.41–0.92 |
Spain | 1.00 | Reference | 1.00 | Reference |
Education | ||||
Low | 1.40 | 1.11–1.76 | 1.46 | 0.99–2.16 |
Medium | 1.45 | 1.15–1.82 | 1.09 | 0.72–1.65 |
High | 1.00 | Reference | 1.00 | Reference |
Front-line COVID-19 | ||||
No | 0.67 | 0.53–0.85 | 1.25 | 0.79–1.99 |
Sometimes | 0.95 | 0.67–1.35 | 1.49 | 0.78–2.84 |
Yes | 1.00 | Reference | 1.00 | Reference |
Health Environment | ||||
Yes | 1.13 | 0.93–1.37 | 0.96 | 0.68–1.35 |
No | 1.00 | Reference | 1.00 | Reference |
Occupation | ||||
Auxiliary or technician | 1.43 | 0.9–2.27 | 0.93 | 0.36–2.40 |
Commercial or administrative | 2.65 | 1.09–6.43 | 1.15 | 0.22–6.09 |
Nurse | 1.26 | 0.90–1.77 | 0.80 | 0.39–1.64 |
Medical Doctor (MD) | 1.37 | 1.09–1.70 | 1.72 | 0.94–3.16 |
Other health professionals | 1.82 | 1.08–3.08 | 0.62 | 0.17–2.21 |
Students/Unemployed/Retired | 1.36 | 1.09–1.70 | 1.87 | 1.29–2.72 |
Non-sanitary | 1.00 | Reference | 1.00 | Reference |
Vaccination status | ||||
No, because I refused | 0.03 | 0.02–0.05 | 1.50 | 0.32–1.73 |
No, due to other reason | 0.96 | 0.66–1.39 | 0.66 | 0.32–1.34 |
Only partially | 0.81 | 0.59–1.10 | 0.85 | 0.51–1.44 |
Yes, and I got the necessary doses | 1.00 | Reference | 1.00 | Reference |
Violation of human rights | ||||
No | 16.04 | 12.64–20.35 | 2.88 | 1.98–4.20 |
I don’t know | 2.96 | 2.11–4.16 | 3.21 | 1.98–5.17 |
Yes | 1.00 | Reference | 1.00 | Reference |
Yes vs. No | I Would Have Doubts vs. No | |||
---|---|---|---|---|
Gender | aOR | 95% CI | aOR | 95% CI |
Male | 0.82 | 0.63–1.09 | 0.64 | 0.43–0.95 |
Female | 1.00 | Reference | 1.00 | Reference |
Age | 1.01 | 1.00–1.02 | 0.99 | 0.98–1.01 |
Country | ||||
Colombia | 6.16 | 4.21–9.03 | 2.65 | 1.65–4.26 |
El Salvador | 1.54 | 1.06–2.24 | 1.43 | 0.88–2.34 |
Spain | 1.00 | Reference | 1.00 | Reference |
Education | ||||
Low | 0.79 | 0.58–1.07 | 1.46 | 0.99–2.16 |
Medium | 1.69 | 1.18–2.42 | 1.85 | 1.15–2.97 |
High | 1.00 | Reference | 1.00 | Reference |
Front-line COVID-19 | ||||
No | 0.81 | 0.58–1.12 | 1.25 | 0.79–1.99 |
Sometimes | 0.85 | 0.54–1.33 | 1.49 | 0.78–2.84 |
Yes | 1.00 | Reference | 1.00 | Reference |
Health Environment | ||||
Yes | 1.64 | 1.24–2.16 | 1.02 | 0.70–1.49 |
No | 1.00 | Reference | 1.00 | Reference |
Occupation | ||||
Auxiliary or technician | 1.12 | 0.60–2.08 | 0.77 | 0.33–1.83 |
Commercial or administrative | 2.26 | 0.65–7.88 | 0.34 | 0.03–3.78 |
Nurse | 2.44 | 1.33–4.46 | 0.77 | 0.32–1.83 |
Medical Doctor (MD) | 2.34 | 1.22–4.45 | 1.00 | 0.42–2.43 |
Other health professionals | 2.07 | 0.90–4.76 | 1.32 | 0.46–3.80 |
Students/Unemployed/Retired | 1.08 | 0.80–1.45 | 0.82 | 0.55–1.23 |
Non-sanitary | 1.00 | Reference | 1.00 | Reference |
Vaccination status | ||||
No, because I refused | 0.01 | 0.00–0.01 | 0.06 | 0.03–0.12 |
No, due to other reasons | 0.68 | 0.66–1.39 | 0.66 | 0.32–1.34 |
Only partially | 0.81 | 0.59–1.10 | 0.85 | 0.51–1.44 |
Yes, and I got the necessary doses | 1.00 | Reference | 1.00 | Reference |
Violation of human rights | ||||
No | 8.65 | 6.44–11.61 | 1.87 | 0.24–14.80 |
I don’t know | 3.07 | 1.89–4.96 | 4.13 | 2.35–7.24 |
Yes | 1.00 | Reference | 1.00 | Reference |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Iguacel, I.; Álvarez-Najar, J.P.; Vásquez, P.d.C.; Alarcón, J.; Orte, M.Á.; Samatán, E.; Martínez-Jarreta, B. Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain. Vaccines 2022, 10, 781. https://doi.org/10.3390/vaccines10050781
Iguacel I, Álvarez-Najar JP, Vásquez PdC, Alarcón J, Orte MÁ, Samatán E, Martínez-Jarreta B. Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain. Vaccines. 2022; 10(5):781. https://doi.org/10.3390/vaccines10050781
Chicago/Turabian StyleIguacel, Isabel, Juan Pablo Álvarez-Najar, Patricia del Carmen Vásquez, Judith Alarcón, María Ángeles Orte, Eva Samatán, and Begoña Martínez-Jarreta. 2022. "Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain" Vaccines 10, no. 5: 781. https://doi.org/10.3390/vaccines10050781